Folgen
Hubert Fernandez
Hubert Fernandez
Director, Center for Neurological Restoration, Cleveland Clinic
Bestätigte E-Mail-Adresse bei ccf.org
Titel
Zitiert von
Zitiert von
Jahr
Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): scale presentation and clinimetric testing results
CG Goetz, BC Tilley, SR Shaftman, GT Stebbins, S Fahn, ...
Movement disorders: official journal of the Movement Disorder Society 23 (15 …, 2008
64012008
Genome-wide association study reveals genetic risk underlying Parkinson's disease
J Simon-Sanchez, C Schulte, JM Bras, M Sharma, JR Gibbs, D Berg, ...
Nature genetics 41 (12), 1308-1312, 2009
22032009
Rotenone, paraquat, and Parkinson’s disease
CM Tanner, F Kamel, GW Ross, JA Hoppin, SM Goldman, M Korell, ...
Environmental health perspectives 119 (6), 866-872, 2011
16462011
The Parkinson progression marker initiative (PPMI)
K Marek, D Jennings, S Lasch, A Siderowf, C Tanner, T Simuni, C Coffey, ...
Progress in neurobiology 95 (4), 629-635, 2011
15342011
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
CW Olanow, K Kieburtz, P Odin, AJ Espay, DG Standaert, HH Fernandez, ...
The Lancet Neurology 13 (2), 141-149, 2014
7282014
Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial
MS Okun, HH Fernandez, SS Wu, L Kirsch‐Darrow, D Bowers, F Bova, ...
Annals of Neurology: Official Journal of the American Neurological …, 2009
6072009
Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial
P Ponikowski, BA Kirwan, SD Anker, T McDonagh, M Dorobantu, ...
The Lancet 396 (10266), 1895-1904, 2020
5902020
Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group
B Ravina, K Marder, HH Fernandez, JH Friedman, W McDonald, ...
Movement Disorders 22 (8), 1061-1068, 2007
5872007
Management of referred deep brain stimulation failures: a retrospective analysis from 2 movement disorders centers
MS Okun, M Tagliati, M Pourfar, HH Fernandez, RL Rodriguez, ...
Archives of neurology 62 (8), 1250-1255, 2005
5112005
Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data
HC Fung, S Scholz, M Matarin, J Simón-Sánchez, D Hernandez, A Britton, ...
The Lancet Neurology 5 (11), 911-916, 2006
4692006
Aspiration and swallowing in Parkinson disease and rehabilitation with EMST: a randomized trial
MS Troche, MS Okun, JC Rosenbek, N Musson, HH Fernandez, ...
Neurology 75 (21), 1912-1919, 2010
4522010
Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease
JH Kang, DJ Irwin, AS Chen-Plotkin, A Siderowf, C Caspell, CS Coffey, ...
JAMA neurology 70 (10), 1277-1287, 2013
4242013
The Parkinson's progression markers initiative (PPMI)–establishing a PD biomarker cohort
K Marek, S Chowdhury, A Siderowf, S Lasch, CS Coffey, ...
Annals of clinical and translational neurology 5 (12), 1460-1477, 2018
3952018
Dissociating apathy and depression in Parkinson disease
L Kirsch-Darrow, HF Fernandez, M Marsiske, MS Okun, D Bowers
Neurology 67 (1), 33-38, 2006
3892006
A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease
IH Richard, MP McDermott, R Kurlan, JM Lyness, PG Como, N Pearson, ...
Neurology 78 (16), 1229-1236, 2012
3882012
Donepezil for dementia in Parkinson’s disease: a randomised, double blind, placebo controlled, crossover study
B Ravina, M Putt, A Siderowf, JT Farrar, M Gillespie, A Crawley, ...
Journal of Neurology, Neurosurgery & Psychiatry 76 (7), 934-939, 2005
3512005
Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors
V Voon, M Pessiglione, C Brezing, C Gallea, HH Fernandez, RJ Dolan, ...
Neuron 65 (1), 135-142, 2010
3322010
SNCA variants are associated with increased risk for multiple system atrophy
SW Scholz, H Houlden, C Schulte, M Sharma, A Li, D Berg, A Melchers, ...
Annals of Neurology: Official Journal of the American Neurological …, 2009
3222009
A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit
MF Beal, D Oakes, I Shoulson, C Henchcliffe, WR Galpern, R Haas, ...
JAMA neurology 71 (5), 543-552, 2014
2982014
Pathophysiology and treatment of psychosis in Parkinson’s disease: a review
LB Zahodne, HH Fernandez
Drugs & aging 25, 665-682, 2008
2832008
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20